Telmisartan in ONTARGET, TRANSCEND and PRoFESS: key learnings and perspectives ; supplement proceedings based on data presented at a symposium organised by Bayer Schering Pharma in October 2008 in Athens, Greece
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Hagerstown, MD
Wolters Kluwer Health, Lippincott Williams & Wilkins
2009
|
| Schriftenreihe: | Journal of hypertension
Supplement ; 27,2 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | 50 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV035577641 | ||
| 003 | DE-604 | ||
| 005 | 20090625 | ||
| 007 | t | ||
| 008 | 090623s2009 d||| |||| 10||| eng d | ||
| 035 | |a (OCoLC)634878322 | ||
| 035 | |a (DE-599)BVBBV035577641 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-19 | ||
| 245 | 1 | 0 | |a Telmisartan in ONTARGET, TRANSCEND and PRoFESS |b key learnings and perspectives ; supplement proceedings based on data presented at a symposium organised by Bayer Schering Pharma in October 2008 in Athens, Greece |c ed.: Alejandro de la Sierra ... |
| 264 | 1 | |a Hagerstown, MD |b Wolters Kluwer Health, Lippincott Williams & Wilkins |c 2009 | |
| 300 | |a 50 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Journal of hypertension : Supplement |v 27,2 | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 700 | 1 | |a Sierra, Alejandro de la |e Sonstige |4 oth | |
| 830 | 0 | |a Journal of hypertension |v Supplement ; 27,2 |w (DE-604)BV021288219 |9 27,2 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017633107&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-017633107 | ||
Datensatz im Suchindex
| _version_ | 1804139234046509057 |
|---|---|
| adam_text | Titel: Telmisartan in ONTARGET, TRANSCEND and PRoFESS
Autor: Sierra, Alejandro de^la
Jahr: 2009
Table of contents
SI Foreword
Gianfranco Parati and Alejandro de la Sierra
S3 Benefits of the RAS blockade: clinical evidence before the ONTARGET study
Christine Perret-Guillaume, Laure Joly, Piotr Jankowski and Athanase Benetos
S8 Focus on the ONTARGET results
Henry L. Elliott
Sll Dual blockade versus single blockade of the renin-angiotensin system in the light of ONTARGET
Isabella Sudano and Georg Noll
S15 How to achieve renal protection in the light of ONTARGET?
Christos Chatzikyrkou, Jan Menne and Hermann Haller
S18 Practical aspects of treatment discontinuation and adherence
Gianfranco Parati and Grzegorz Bilo
S22 Main results and clinical interpretations from the TRANSCEND study
Alejandro de la Sierra
S26 Prevention of major cardiovascular events with an angiotensin-converting enzyme inhibitor or an angiotensin
receptor blocker early or late after stroke
Walter Van Mieghem
S32 The question of heart failure in ONTARGET and TRANSCEND: implications for clinical practice
Jose R. Gonzalez-Juanatey
S36 ONTARGET, TRANSCEND, and PRoFESS: new-onset diabetes, atrial fibrillation, and left ventricular
hypertrophy
Ulrich Kintscher
S40 Implementation of new evidence into hypertension guidelines: the case of the ONTARGET and
TRANSCEND trials
Guido Grassi and Giuseppe Mancia
S45 Endpoints in clinical trials: does evidence only originate from hard or mortality endpoints?
Roland Asmar and Hassan Hosseini
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV035577641 |
| ctrlnum | (OCoLC)634878322 (DE-599)BVBBV035577641 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01366nam a2200289 cb4500</leader><controlfield tag="001">BV035577641</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20090625 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">090623s2009 d||| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)634878322</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV035577641</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Telmisartan in ONTARGET, TRANSCEND and PRoFESS</subfield><subfield code="b">key learnings and perspectives ; supplement proceedings based on data presented at a symposium organised by Bayer Schering Pharma in October 2008 in Athens, Greece</subfield><subfield code="c">ed.: Alejandro de la Sierra ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hagerstown, MD</subfield><subfield code="b">Wolters Kluwer Health, Lippincott Williams & Wilkins</subfield><subfield code="c">2009</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">50 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Journal of hypertension : Supplement</subfield><subfield code="v">27,2</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sierra, Alejandro de la</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Journal of hypertension</subfield><subfield code="v">Supplement ; 27,2</subfield><subfield code="w">(DE-604)BV021288219</subfield><subfield code="9">27,2</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017633107&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-017633107</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV035577641 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T21:40:50Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-017633107 |
| oclc_num | 634878322 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-19 DE-BY-UBM |
| owner_facet | DE-355 DE-BY-UBR DE-19 DE-BY-UBM |
| physical | 50 S. graph. Darst. |
| publishDate | 2009 |
| publishDateSearch | 2009 |
| publishDateSort | 2009 |
| publisher | Wolters Kluwer Health, Lippincott Williams & Wilkins |
| record_format | marc |
| series | Journal of hypertension |
| series2 | Journal of hypertension : Supplement |
| spelling | Telmisartan in ONTARGET, TRANSCEND and PRoFESS key learnings and perspectives ; supplement proceedings based on data presented at a symposium organised by Bayer Schering Pharma in October 2008 in Athens, Greece ed.: Alejandro de la Sierra ... Hagerstown, MD Wolters Kluwer Health, Lippincott Williams & Wilkins 2009 50 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Journal of hypertension : Supplement 27,2 (DE-588)1071861417 Konferenzschrift gnd-content Sierra, Alejandro de la Sonstige oth Journal of hypertension Supplement ; 27,2 (DE-604)BV021288219 27,2 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017633107&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Telmisartan in ONTARGET, TRANSCEND and PRoFESS key learnings and perspectives ; supplement proceedings based on data presented at a symposium organised by Bayer Schering Pharma in October 2008 in Athens, Greece Journal of hypertension |
| subject_GND | (DE-588)1071861417 |
| title | Telmisartan in ONTARGET, TRANSCEND and PRoFESS key learnings and perspectives ; supplement proceedings based on data presented at a symposium organised by Bayer Schering Pharma in October 2008 in Athens, Greece |
| title_auth | Telmisartan in ONTARGET, TRANSCEND and PRoFESS key learnings and perspectives ; supplement proceedings based on data presented at a symposium organised by Bayer Schering Pharma in October 2008 in Athens, Greece |
| title_exact_search | Telmisartan in ONTARGET, TRANSCEND and PRoFESS key learnings and perspectives ; supplement proceedings based on data presented at a symposium organised by Bayer Schering Pharma in October 2008 in Athens, Greece |
| title_full | Telmisartan in ONTARGET, TRANSCEND and PRoFESS key learnings and perspectives ; supplement proceedings based on data presented at a symposium organised by Bayer Schering Pharma in October 2008 in Athens, Greece ed.: Alejandro de la Sierra ... |
| title_fullStr | Telmisartan in ONTARGET, TRANSCEND and PRoFESS key learnings and perspectives ; supplement proceedings based on data presented at a symposium organised by Bayer Schering Pharma in October 2008 in Athens, Greece ed.: Alejandro de la Sierra ... |
| title_full_unstemmed | Telmisartan in ONTARGET, TRANSCEND and PRoFESS key learnings and perspectives ; supplement proceedings based on data presented at a symposium organised by Bayer Schering Pharma in October 2008 in Athens, Greece ed.: Alejandro de la Sierra ... |
| title_short | Telmisartan in ONTARGET, TRANSCEND and PRoFESS |
| title_sort | telmisartan in ontarget transcend and profess key learnings and perspectives supplement proceedings based on data presented at a symposium organised by bayer schering pharma in october 2008 in athens greece |
| title_sub | key learnings and perspectives ; supplement proceedings based on data presented at a symposium organised by Bayer Schering Pharma in October 2008 in Athens, Greece |
| topic_facet | Konferenzschrift |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017633107&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV021288219 |
| work_keys_str_mv | AT sierraalejandrodela telmisartaninontargettranscendandprofesskeylearningsandperspectivessupplementproceedingsbasedondatapresentedatasymposiumorganisedbybayerscheringpharmainoctober2008inathensgreece |